Related Experiment Video
Updated: May 15, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function
Feng Gao1, Hansel E Ihn, Marisa W Medina
1Children’s Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, USA.
The rs688 genetic variant in the low-density lipoprotein receptor (LDLR) gene affects LDLR protein levels and function, impacting LDL cholesterol regulation. This synonymous SNP influences LDLR activity beyond alternative splicing, potentially affecting cardiovascular health.
Area of Science:
- Genetics
- Molecular Biology
- Cardiovascular Research
Background:
- The synonymous single nucleotide polymorphism (SNP) rs688 in the low-density lipoprotein receptor (LDLR) gene is linked to elevated plasma LDL cholesterol.
- Previous studies suggested rs688 influences LDLR mRNA via alternative splicing and nonsense-mediated decay (NMD).
Purpose of the Study:
- To investigate the functional impact of the synonymous SNP rs688 on full-length LDLR protein and function.
- To determine if rs688 affects LDLR activity through mechanisms beyond alternative splicing.
Main Methods:
- Utilized HepG2 cells expressing LDLR cDNA constructs with either the major or minor allele of rs688.
- Quantified cell surface and lysosomal LDLR protein levels.
- Assessed LDL uptake and response to PCSK9 inhibition.
Main Results:
- The minor allele of rs688 was associated with reduced cell surface LDLR protein and increased lysosomal localization.
- LDL uptake was decreased in cells expressing the minor allele of rs688.
- The minor allele impaired the efficacy of a PCSK9 antibody in enhancing LDL uptake.
Conclusions:
- The synonymous SNP rs688 impacts LDLR protein function, affecting LDLR endosomal recycling and/or PCSK9 binding.
- These findings suggest rs688 influences LDLR activity through co-translational effects, independent of its impact on alternative splicing.
- rs688 represents a functional genetic variant with implications for LDL cholesterol metabolism and cardiovascular risk.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
Multiple Allele Traits
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Drug Metabolism: Overview
